← Leaderboards
Changmeng Cai
Beth Israel Deaconess Medical Center
$4,011,441
Attributed
$4,011,441
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $832.3K · FY2012–25$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,011,441 · 7
By mechanism
R01$2,566,065 · 3
R00$726,206 · 1
U54$449,278 · 2
K99$269,892 · 1
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Ming Hui Chen$4,823,776
- Xin Yuan$3,922,786
- Manoj Bhasin$2,768,871
- Daoyuan Huang$169,884
Others in their field
Top investigators on “Malignant Neoplasm Of Prostate”
- David Heimbrook · Leidos Biomedical Research, Inc.$255,843,614
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Walter John Curran · Thomas Jefferson University$61,298,085
- Norman Wolmark · Nsabp Foundation, Inc.$54,888,134
- James J. Dignam · University Of Chicago$48,310,409
- Laurence H Baker · University Of Michigan At Ann Arbor$43,366,962
Research focus
Malignant Neoplasm Of ProstateGenetic TranscriptionAndrogen ReceptorProstate Cancer CellPlayAndrogensMediatingKdm1a GeneChromatinTumorMolecularPreventGenesSiteGene RepressionComplexGene ExpressionProgramsGenome-WideDna BiosynthesisProstate Cancer ModelPhosphorylationCancer PatientCell Cycle Progression
Grant awards (15)
Noncanonical activities of SETD7 in preventing prostate cancer progression andtherapy resistance$416,409
R01 · FY2025 · CA · contact PI
Targeting FOXA2/AP-1 axis to overcome lineage plasticity and therapy resistance in castration-resistant prostate cancer$415,902
R01 · FY2025 · CA · contact PI
Targeting androgen receptor signaling in prostate cancer in men with African ancestry$147,328
U54 · FY2023 · CA · contact PI
Targeting androgen receptor signaling in prostate cancer in men with African ancestry$149,450
U54 · FY2022 · CA · contact PI
Study the Mechanism of Retinoblastoma Protein Mediated Androgen Receptor Transcriptional Repression Activity on DNA Replication$348,844
R01 · FY2021 · CA · contact PI
Targeting androgen receptor signaling in prostate cancer in men with African ancestry$152,500
U54 · FY2021 · CA · contact PI
Study the Mechanism of Retinoblastoma Protein Mediated Androgen Receptor Transcriptional Repression Activity on DNA Replication$348,844
R01 · FY2020 · CA · contact PI
Study the Mechanism of Retinoblastoma Protein Mediated Androgen Receptor Transcriptional Repression Activity on DNA Replication$338,378
R01 · FY2019 · CA · contact PI
Study the Mechanism of Retinoblastoma Protein Mediated Androgen Receptor Transcriptional Repression Activity on DNA Replication$348,844
R01 · FY2018 · CA · contact PI
Study the Mechanism of Retinoblastoma Protein Mediated Androgen Receptor Transcriptional Repression Activity on DNA Replication$348,844
R01 · FY2017 · CA · contact PI
Molecular basis of androgen receptor mediated gene transcriptional repression$237,796
R00 · FY2017 · CA · contact PI
Molecular basis of androgen receptor mediated gene transcriptional repression$242,182
R00 · FY2016 · CA · contact PI
Molecular basis of androgen receptor mediated gene transcriptional repression$246,228
R00 · FY2015 · CA · contact PI
Molecular basis of androgen receptor mediated gene transcriptional repression$134,946
K99 · FY2013 · CA · contact PI
Molecular basis of androgen receptor mediated gene transcriptional repression$134,946
K99 · FY2012 · CA · contact PI